Patent · US Active

Compositions and methods of treating muscle dystrophy

US11707532B2 · kind B2 · utility

1Cited by
82References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 8, 2022
Grant dateJul 25, 2023
Priority date—
Expiry dateAug 8, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle dystrophy (DM1).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.